MoCRA compliance turned US cosmetics from one of the world's lightest regulatory regimes into one with real registration duties. For an importer the sting is in a single clause: where no US entity appears on the label, you become the Responsible Person — and every obligation that follows lands on your company, not on the brand you are importing.
What MoCRA actually changed
For decades the United States regulated cosmetics more lightly than almost any comparable market. The Modernization of Cosmetics Regulation Act ended that. MoCRA compliance now requires facilities to register with the FDA, products to be listed, safety substantiation to exist on file, and adverse events to be reported.
The deadlines have already passed. Facilities faced an initial December 2023 deadline, and existing facilities had to register by 1 July 2024. Products already on the market by December 2023 needed listing by that same July date. New products get 120 days from entering the market (FDA).
For an importer arriving now, none of that history matters except in one respect: you are entering a system that is already live and enforced, not one being phased in. There is no grace period left to plan around.
Facility registration and product listing
Two separate obligations sit at the centre of MoCRA compliance, and importers regularly confuse them. Getting MoCRA compliance right starts with keeping them apart.
Facility registration applies to the establishment that manufactures or processes the cosmetic. For imported product that means the foreign manufacturing site — your Turkish, Korean or Italian supplier's factory. That site itself has to hold an FDA registration, and the registration renews every two years.
Product listing applies to each cosmetic product you market in the US, and captures the product category, ingredient list and the producing facility. Listings need an annual update.
Two practical consequences follow:
- You depend on your supplier for the facility registration number. You cannot list a product without identifying a registered facility. A manufacturer who has not registered blocks your entire US launch, and you will only discover this when you try to file.
- Changes propagate. Reformulate, switch producing site or alter the ingredient statement, and you update the listing — generally within 60 days.
Ask for the FDA facility registration number in writing before you negotiate price. It takes one email, and a supplier who cannot produce one is not export-ready for the United States regardless of what their catalogue says.
The Responsible Person trap for importers
This is the MoCRA compliance clause that catches non-US brands and their distributors hardest.
Under MoCRA the Responsible Person is whichever entity the product label names. Where no US entity appears there, the US importer is treated as the Responsible Person. That is not a default you opt into — it follows automatically from the label.
The role carries the substantive duties: maintaining safety substantiation records, receiving and reporting serious adverse events, and ensuring the product listing stays current. It also carries the reputational exposure, because your company is the name a consumer or a regulator contacts.
Two ways to handle it, both legitimate:
- Accept the role knowingly. Put your entity on the label, build the record-keeping, and treat it as part of the cost of holding the brand in your market. This is the normal path for a distributor with exclusivity ambitions.
- Require the brand owner to establish a US presence. Larger brands sometimes do this. Most Turkish and European mid-size manufacturers will not, and pretending otherwise wastes months.
What you should never do is sign a distribution agreement without deciding which of the two applies. Importing cosmetics to the USA under an unexamined assumption about who carries the Responsible Person duties is how distributors end up holding obligations they never priced.
Safety substantiation and adverse events
MoCRA requires adequate substantiation of safety for each cosmetic product. It does not prescribe a single format the way the EU prescribes a Cosmetic Product Safety Report, which sounds easier and is in fact harder — you have to decide what "adequate" means and be able to defend it.
In practice a defensible file contains:
- The full quantitative formula and INCI declaration
- Toxicological assessment or reasoned read-across for each ingredient
- Stability and preservative efficacy testing
- Compatibility data for the packaging
- Evidence supporting every claim printed on the pack
Serious adverse event reporting is a hard fifteen-business-day obligation from receipt. The operational implication is unglamorous but real: you need a monitored inbox and a written procedure before you sell the first unit, not after you receive the first complaint. Retailers and marketplaces will ask about this during onboarding.
You keep the records supporting safety substantiation and adverse event reports, and produce them on request, so build the filing system at the start.
What to demand from your manufacturer
Your supplier cannot file for you, but MoCRA compliance depends on inputs only they hold. Ask for these before committing:
| What to request | Why MoCRA compliance needs it |
|---|---|
| FDA facility registration number | You cannot list a product without it |
| Full quantitative formula | Underpins safety substantiation |
| INCI declaration | Product listing and label copy |
| Stability and challenge testing | Part of a defensible safety file |
| GMP evidence | Expected practice, and increasingly requested by trade buyers |
| Editable artwork | Adding your US entity, the required panels and net contents |
Colour additives deserve a separate check. The US operates its own approved list with specific certification requirements, and a colourant that is legal in the EU is not automatically legal in the United States. Screen this early — it is the single most common reformulation trigger for European and Turkish product entering the US.
Growman supplies the technical file behind our 26 export references in the form your filings need. What we will not do is claim a registration status we cannot evidence, in the US or anywhere else.
Where MoCRA compliance meets commercial reality
Regulation shapes the deal structure, and importers who ignore that end up renegotiating later.
Exclusivity gets more expensive to grant and more valuable to hold. If you carry the Responsible Person duties, you are carrying real cost and real liability. That is a legitimate argument for territory protection, and a reasonable brand owner will recognise it.
Reformulation risk sits with you commercially even when it sits with the manufacturer technically. A colourant that fails US screening, or an ingredient the FDA restricts later, becomes your stock problem. Write the remedy into the agreement before the first order rather than discovering there isn't one.
Small trial orders make MoCRA compliance uneconomic. Facility dependency, safety substantiation and the reporting procedure are largely fixed costs. Spread across a few hundred units they can exceed gross margin; spread across a real opening assortment they are modest. This is the same arithmetic that argues for a proper first order in every regulated market.
The label decision is strategic. Putting your entity on pack makes you the Responsible Person but also makes you the brand's visible presence in the market. Distributors planning a long relationship usually want that. Ones testing the water usually do not, and should say so early.
Anyone importing cosmetics to the USA should settle these four points in the term sheet, not in the first crisis.
Frequently asked questions
Who is the Responsible Person for imported cosmetics under MoCRA?
The entity named on the product label. Where no US entity appears on the label, the US importer takes the role, along with safety substantiation, adverse event reporting and product listing duties.
Does my foreign manufacturer have to register with the FDA?
Yes. Facilities that manufacture or process cosmetics for the US market must register, including facilities outside the United States. Ask for the registration number before you order, because you cannot complete product listing without it.
How often do MoCRA filings need updating?
Product listings require an annual update, facility registrations renew every two years, and material changes generally need reporting within 60 days. Reformulations and site changes both count as material.
Is a US agent the same as the Responsible Person?
No. A foreign facility must designate a US agent for registration purposes, which is an administrative contact role. The Responsible Person carries the substantive product obligations and is determined by the label.
Evaluating a US launch?
Send us the references you are considering. We supply the INCI declarations, facility details and safety data your MoCRA filings and your label copy will need.
